← Back to Press PAGE

The Role of Real-World Evidence in Accelerating Drug Development

Cure51

Publication Date:

Jul 27, 2025

In today’s tech-driven landscape, few sectors are transforming as rapidly as Life Sciences. One of the most game-changing shifts is the growing reliance on real-world evidence (RWE) to accelerate clinical trials and drug development. This evolution has the potential to bring innovative treatments to market faster, improve patient outcomes, and reduce healthcare costs.

Read more

NEWS

THEY SPREAD THE WORD

Go to Press page

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

Defeating cancer: By identifying the biological mechanisms shared by tens of thousands of survivors of the most aggressive forms of cancer.

Aug 16, 2025

Join us to eradicate Cancer.

ROSALIND

The Role of Real-World Evidence in Accelerating Drug Development

Publication Date:

Jul 27, 2025

Table of Contents

THEY SPREAD THE WORD

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

Cancer Super-Survivors May Hold Keys to New Treatments

Researchers typically ask why people get cancer. What if they studied why some survive — or never develop the disease?

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

The Role of Real-World Evidence in Accelerating Drug Development

Nicolas Wolikow, Co-Founder and CEO at Cure51, on Ethical Principles in TechBio.

Defeating cancer: By identifying the biological mechanisms shared by tens of thousands of survivors of the most aggressive forms of cancer.

Aug 16, 2025